| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.44 | 0.1 |